Brief: AFT Pharmaceuticals Says U.S. FDA Sets PDUFA Date For Maxigesic IV

AFT Pharmaceuticals

01/05/2023 02:08

May 1 (Reuters) - AFT Pharmaceuticals Ltd  AFT.NZ :
    * U.S. FDA SETS PDUFA DATE FOR MAXIGESIC IV
    * U.S. FDA SET 17 OCT 2023 AS DATE BY WHICH IT EXPECTS TO
RESPOND
TO AFT'S APPLICATION TO REGISTER MAXIGESIC IV IN U.S.

Source text for Eikon:  ID:nASX7Phq6j 
Further company coverage:  AFT.NZ 

 ((Reuters.Briefs@thomsonreuters.com;))